Abstract

Enterohemorrhagic E. coli (EHEC) is a human intestinal pathogen that causes hemorrhagic colitis and hemolytic uremic syndrome. No vaccines or specific therapies are currently available to prevent or treat these infections. EHEC tightly attaches to the intestinal epithelium by injecting the intimin receptor Tir into the host cell via a type III secretion system (T3SS). In this project, we identified a camelid single domain antibody (nanobody), named TD4, that recognizes a conserved Tir epitope overlapping the binding site of its natural ligand intimin with high affinity and stability. We show that TD4 inhibits attachment of EHEC to cultured human HeLa cells by preventing Tir clustering by intimin, activation of downstream actin polymerization and pedestal formation. Furthermore, we demonstrate that TD4 significantly reduces EHEC adherence to human colonic mucosa in in vitro organ cultures. Altogether, these results suggest that nanobody-based therapies hold potential in the development of much needed treatment and prevention strategies against EHEC infection.

Highlights

  • Enterohemorrhagic E. coli (EHEC) is a major public health concern in industrial countries with most severe infections linked to serotype O157:H7

  • Our results show the potential of this nanobody to prevent and treat EHEC infection

  • This is mediated by the Locus of Enterocyte Effacement (LEE) [8], a pathogenicity island encoding a filamentous type III secretion system (T3SS) [9, 10], the outer membrane adhesin intimin and the translocated intimin receptor (Tir), and other effector proteins involved in pathogenesis [11, 12]

Read more

Summary

Introduction

Enterohemorrhagic E. coli (EHEC) is a major public health concern in industrial countries with most severe infections linked to serotype O157:H7. EHEC adheres to the epithelium of the distal ileum and colon by forming attaching and effacing (A/E) lesions, which are characterized by intimate bacterial attachment and effacement of the brush border microvilli [6, 7]. This is mediated by the Locus of Enterocyte Effacement (LEE) [8], a pathogenicity island encoding a filamentous type III secretion system (T3SS) [9, 10], the outer membrane adhesin intimin and the translocated intimin receptor (Tir), and other effector proteins involved in pathogenesis [11, 12]. Binding of intimin to Tir leads to intimate bacterial attachment, Tir clustering, activation of actin polymerization pathways and subsequent formation of actin pedestals and A/E lesions [7, 18,19,20,21,22]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call